Viral Endothelial Dysfunction: A Unifying Mechanism for COVID-19

Area of Science:

• Cardiovascular Science
• Infectious Disease
• Pathology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes significant global morbidity and mortality.
• SARS-CoV-2 infection can lead to multi-organ manifestations, including acute respiratory distress syndrome, renal failure, thromboembolism, and myocarditis.
• Virus-induced endothelial injury is implicated in inflammation, immune response, and cytokine storm.

Purpose of the Study:

• To explore the association between SARS-CoV-2 infection and endothelial dysfunction.
• To highlight the role of endothelial dysfunction in systemic inflammation and multiorgan involvement.
• To emphasize the potential of noninvasive endothelial function monitoring for risk stratification and improved patient outcomes.

Main Methods:

• Literature review of studies investigating SARS-CoV-2 and endothelial function.
• Analysis of mechanisms linking viral infection to endothelial activation and dysfunction.
• Exploration of the relationship between endothelial dysfunction, inflammation, and cardiovascular risk.

Main Results:

• SARS-CoV-2 infection is associated with inflammation and endothelial dysfunction.
• Endothelial dysfunction is a precursor to atherosclerotic vascular disease and is prevalent in at-risk populations.
• Viral infections, including SARS-CoV-2, can trigger innate immune responses and cytokine storms via endothelial injury.

Conclusions:

• Endothelial dysfunction is a critical factor in the pathogenesis of SARS-CoV-2-related complications.
• Noninvasive monitoring of endothelial function may identify patients at high risk for severe outcomes.
• Targeted therapies for endothelial dysfunction could potentially reduce morbidity and mortality in SARS-CoV-2 patients.